CHICAGO (PRWEB) January 11, 2019
DiabetesSisters is pleased to announce its 2019 National Strategic Partners, including Corporate Advisors AstraZeneca, Dexcom, Insulet, Janssen, Lilly and Sanofi. Established in 2018 to collaborate with industry partners, the National Strategic Partnership focuses on needs in the diabetes community and facilitates open conversations between patients and industry to create relevant and valuable programs and services.
The program was designed to collaborate on mutual-interest initiatives; offer ways to better inform the diabetes community of products, services, and assistance programs; and provide patient voices to industry to aid in the understanding of patient needs.
“Welcoming our 2019 Corporate Advisors is a privilege for DiabetesSisters,” said Anna Norton, MS, CEO of DiabetesSisters. “Sitting around the table discussing diabetes challenges is invaluable for the continued growth and success of our patient organization. In turn we are able to offer patient insights, allowing partners to better serve patients.”
A 501(c)(3) nonprofit, DiabetesSisters is the only organization nationwide focusing exclusively on women living with diabetes. Our mission is to improve the health and quality of life of women living with and at risk of developing diabetes and to advocate on their behalf. DiabetesSisters has a 25,000+ member peer support network that unites women with diabetes for the purpose of support, education, and advocacy. Signature programs include monthly peer support meetings (PODS Meetups); the Minority Initiative Program; online blogs, forums, and expert articles; and conferences throughout the US. For more information, visit http://www.diabetessisters.org.